HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells Journal Article


Authors: Nguyen, D. T. T.; Lu, Y.; Chu, K. L.; Yang, X.; Park, S. M.; Choo, Z. N.; Chin, C. R.; Prieto, C.; Schurer, A.; Barin, E.; Savino, A. M.; Gourkanti, S.; Patel, P.; Vu, L. P.; Leslie, C. S.; Kharas, M. G.
Article Title: HyperTRIBE uncovers increased MUSASHI-2 RNA binding activity and differential regulation in leukemic stem cells
Abstract: The cell-context dependency for RNA binding proteins (RBPs) mediated control of stem cell fate remains to be defined. Here we adapt the HyperTRIBE method using an RBP fused to a Drosophila RNA editing enzyme (ADAR) to globally map the mRNA targets of the RBP MSI2 in mammalian adult normal and malignant stem cells. We reveal a unique MUSASHI-2 (MSI2) mRNA binding network in hematopoietic stem cells that changes during transition to multipotent progenitors. Additionally, we discover a significant increase in RNA binding activity of MSI2 in leukemic stem cells compared with normal hematopoietic stem and progenitor cells, resulting in selective regulation of MSI2’s oncogenic targets. This provides a basis for MSI2 increased dependency in leukemia cells compared to normal cells. Moreover, our study provides a way to measure RBP function in rare cells and suggests that RBPs can achieve differential binding activity during cell state transition independent of gene expression. © 2020, The Author(s).
Keywords: signal transduction; controlled study; leukemia; unclassified drug; gene mutation; human cell; nonhuman; flow cytometry; binding affinity; animal cell; mouse; mammalia; animal tissue; gene expression; animal experiment; protein; cell differentiation; enzyme activity; rna binding protein; rna; genetic transfection; leukemogenesis; cancer stem cell; immunoprecipitation; hematopoiesis; gene silencing; bioinformatics; transcriptome; rna splicing; rna extraction; rna sequence; enzyme; dna methyltransferase 3a; gene ontology; rna editing; sanger sequencing; cell component; cancer; human; article; luciferase assay; real time reverse transcription polymerase chain reaction; interleukin enhancer binding factor 3; musashi binding protein
Journal Title: Nature Communications
Volume: 11
ISSN: 2041-1723
Publisher: Nature Publishing Group  
Date Published: 2020-04-24
Start Page: 2026
Language: English
DOI: 10.1038/s41467-020-15814-8
PUBMED: 32332729
PROVIDER: scopus
PMCID: PMC7181745
DOI/URL:
Notes: Article -- Export Date: 1 June 2020 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Christina Leslie
    188 Leslie
  2. Michael Kharas
    98 Kharas
  3. Sun Mi Park
    23 Park
  4. Yuheng Lu
    17 Lu
  5. Camila Prieto
    9 Prieto
  6. Diu Thi Thanh Nguyen
    14 Nguyen
  7. Karen Chu
    9 Chu
  8. Alexandra Schurer
    15 Schurer
  9. Ersilia Barin
    8 Barin
  10. Angela Maria Savino
    6 Savino
  11. Xuejing Yang
    13 Yang